Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
13
Number of overlapping holdings
11.7%
% of IXJ's 111 holdings also in CANC
27.1%
% of CANC's 48 holdings also in IXJ
Overlap by Weight
Sector Drift (IXJ minus CANC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IXJ |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 9.0% | 4.7% | 4.7% |
|
MERCK & CO. INC. | 3.6% | 4.4% | 3.6% |
 |
ASTRAZENECA PLC | 3.0% | 5.9% | 3.0% |
 |
NOVARTIS AG | 2.8% | 3.1% | 2.8% |
|
ABBVIE INC | 4.4% | 2.0% | 2.0% |
Position Highlights (Non-Overlapping Exposures)
IXJ Overweight Relative to CANC
|
UNITEDHEALTH GROUP INC | 6.8% |
|
JOHNSON & JOHNSON | 4.9% |
|
ELI LILLY & CO | 4.3% |
 |
NOVO NORDISK A/S-B | 3.9% |
|
THERMO FISHER SCIENTIFIC INC | 2.9% |
|
ROCHE HOLDING LTD | 2.9% |
|
INTUITIVE SURGICAL INC | 2.8% |
|
ABBOTT LABORATORIES | 2.8% |
|
ABBVIE INC | 2.4% |
|
PFIZER INC | 2.2% |
IXJ Underweight Relative to CANC
|
REVOLUTION MEDICINES, INC. | -4.3% |
|
BRIDGEBIO PHARMA, INC. | -4.1% |
|
GENMAB A/S SPONSORED ADR | -4.1% |
|
EXELIXIS INC | -3.7% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -3.6% |
|
ASTRAZENECA PLC | -2.9% |
|
NUVALENT, INC. CLASS A | -2.8% |
|
BEIGENE LTD. SPONSORED ADR | -2.8% |
|
BLUEPRINT MEDICINES CORP. | -2.7% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -2.6% |